ACIScience Masthead



Advancing the Science Webinar Series:
Chemical-Induced Asthma

Current Clinical Perspectives in Evaluating Chemical Induced Asthma, or "What Caused My Asthma?"

February 25, 2016
Webinar was recorded and is available to registrants.
Dr  Jon Bernstein
Dr. Jon Bernstein

A review of the clinical tests used to diagnose asthma. This speaker will discuss symptom variability and its effect on diagnostic ability.

Learning Objectives:

  • To describe complications in defining asthma as a clinical syndrome
  • To describe methods used to evaluate the cause of a patient’s asthma.
  • To describe future directions in clinical research of chemically-induced asthma

Dr. Jonathan A. Bernstein is Professor of Clinical Medicine at the University of Cincinnati Medical Center and Director of Clinical Research for the Division of Immunology. His current research involves the health effects of UV irradiation units as an environmental intervention installed in the homes of asthmatic children, biomarkers for Trimellitic anhydride sensitization in the workplace, allergenicity of cyanobacteria, phenotyping chronic rhinitis subtypes specifically non-allergic rhinitis, seminal plasma hypersensitivity and angioedema/chronic urticaria. Dr. Bernstein is the Director of Clinical Research at the University of Cincinnati/VAH Clinical Research Unit and is a DIA certified investigator. Dr. Bernstein has been voted "Best Doctor" in Cincinnati from 1999 to 2015 and ranked by US New and World Report as being in the top 1% of doctors in his specialty.

Webinar series sponsored by the American Cleaning Institute (ACI), in collaboration with the Toxicology Excellence for Risk Assessment (TERA) Center, University of Cincinnati and Endorsed by the Society of Toxicology

Asthma Webinar Sponsors


This webinar series will discuss the advances being made with chemical-induced asthma and the role of clinical, toxicological, and epidemiological research in regulatory and hazard characterization approaches. The webinars are free, but registration is required.

  • Session 1:
    Current Clinical Perspectives in Evaluating Chemical Induced Asthma, or "What Caused My Asthma?"
    February 25, 2016 2pm EST
    Jon Bernstein 
  • Session 2:
    The role of toxicology in asthma hazard assessment
    April 28, 2016 2pm EST
    David Basketter
  • Session 3:
    Environmental contributions to asthma prevalence: Assessing the link between exposure and disease
    June 17, 2016 11am EST
    Judy LaKind
  • Session 4:
    Setting Exposure Limits for Chemical Allergens: Understanding the Challenges
    August 26, 2016 11a.m. EST
    Scott Dotson (NIOSH)
  • Session 5:
    Asthma-specific hazard characterization approaches: A novel approach to a complex problem
    October 21, 2016 11am EST
    Andy Maier